Navigation » List of Schools » International College of Health Sciences » Nursing » Nursing 1141- Pharmacology » Fall 2022 » Mastery EAQ Ch. 26
Below are the questions for the exam with the choices of answers:
Question #1
A The dose will be increased.
B The dose will be decreased.
C The medication will be stopped.
D The dose will be unchanged.
Question #2
A Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
B Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
C Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
D Not a candidate for fondaparinux based on an insufficient creatinine clearance
Question #3
A Too low
B Too high
C Inadequate to evaluate treatment
D Within normal limits
Question #4
A Inadequate to evaluate treatment
B Significantly elevated
C Within normal limits
D Significantly decreased
Question #5
A Administer prescribed vitamin K if bruising is observed.
B Stop the medication if the systolic blood pressure drops below 110 mm Hg.
C Assess for dysrhythmias.
D Monitor liver enzymes.
Question #6
A Massaging the site after the injection
B Administering the medication when convenient
C Checking if the patient’s prescription contains enoxaparin
D Administering the medication intramuscularly in the vastus lateralis
Question #7
A “I refrain from drinking coffee and citrus fruit juices daily.”
B “I take ginkgo supplements for memory enhancement.”
C “I do not take aspirin for pain relief.”
D “I eat 1 cup of green leafy vegetables daily.”
Question #8
A “I never sit with my legs crossed at the knees.”
B “I avoid tight-fitting stockings or leggings.”
C “I’ve been on prolonged bed rest.”
D “I get up and walk around at least once an hour.”
Question #9
A Phytonadione
B Alteplase
C Aminocaproic acid
D Tranexamic acid
Question #10
A Cholestyramine
B Barbiturate
C Cimetidine
D Carbamazepine
Question #11
A Heart rate, Hemoglobin, Blood pressure
B Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
C Platelet count, Heart rate, Blood pressure
D Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
Question #12
A “I will use the medication within 60 days after it is opened.”
B “I will place the pills in an organizer for easy use.”
C “I will take the medication with food.”
D “I will store the bottle in a dry place.”
Question #13
A Platelet count of 80,000/mm3
B Diagnosis of diabetes mellitus
C Loss of 10 pounds
D Creatinine clearance of 25 mL/min
Question #14
A The dosage of the warfarin will be decreased by half.
B The dosage of the warfarin will be increased by half.
C The dosage of the amiodarone will be increased by half.
D The dosage of the amiodarone will be decreased by half.
Question #15
A Continue to administer cimetidine with each dose of warfarin.
B Instruct the patient to notify the nurse if he or she begins to experience discomfort.
C Monitor the patient for increased action of the anticoagulant.
D Monitor the patient for decreased action of the anticoagulant.
Question #16
A Local thrombosis from a peripheral intravenous line
B Severe chest pain for the past 2 hours
C Peptic ulcer disease
D Gastrointestinal bleed
Question #17
A Monitor the patient and check the therapeutic range.
B Increase the dose of heparin.
C Notify the health care provider immediately.
D Stop the medication.
Question #18
A Outside the expected target therapeutic level of anticoagulation; it is too low
B Within the expected target therapeutic level of anticoagulation
C Cannot be interpreted without knowing the prothrombin time and international normalized ratio
D Outside the expected target therapeutic level of anticoagulation; it is too high
Question #19
A Platelet count: 100,000/mm3
B Hemoglobin level: 11 g/dL
C Prothrombin time: 13 sec
D Leukocyte count: 3000 cells/mm3
Question #20
A Peptic ulcer disease, Chronic kidney disease
B Atrial fibrillation, History of myocardial infarction
C Chronic obstructive pulmonary disease, Atrial fibrillation
D History of myocardial infarction, Chronic obstructive pulmonary disease
Question #21
A Potassium level of 3.5 mEq/L
B Platelet count of 95,000/mm3
C International normalized ratio (INR) of 1
D Activated partial thromboplastin time (aPTT) of 37 seconds
Question #22
A Within the expected target therapeutic level of anticoagulation
B The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
C Outside the expected target therapeutic level of anticoagulation; it is too high
D Outside the expected target therapeutic level of anticoagulation; it is too low
Question #23
A “Discard the drug within 21 days of opening the original container.”
B “Remove from the original package and place in aluminum foil.”
C “Refrigerate and keep away from direct sunlight.”
D “Store the drug with the desiccant-drying agent in the packing cap.”
Question #24
A Amiodarone
B Enoxaparin
C Ketoconazole
D Furosemide
Question #25
A Monitor the patient’s laboratory values correctly.
B Teach the patient about dietary restrictions while on the medication.
C Ensure that a loading dose was initially administered when beginning
D Have protamine sulfate readily available at all times.
Question #26
A Stop the intravenous (IV) drip.
B Administer vitamin K1 (phytonadione) IV.
C Wait for the INR to decrease.
D Administer protamine sulfate IV.
Question #27
A Dissolution of the clot that caused the heart attack
B Reversal of damage from the infarction
C Prevention of new clots from forming
D A quick decrease in pain
Question #28
A “I should refrain from eating broccoli during the therapy.”
B “I should not use any acetaminophen during the therapy.”
C “I should take oral contraceptives during the therapy.”
D “I should follow a low-cholesterol diet during the therapy.”
Question #29
A “I should use a soft toothbrush for dental hygiene.”
B “I will double my dose if I forget to take it the day before.”
C “I should keep taking ibuprofen for my arthritis.”
D “I should decrease the dose if I start bruising easily.”
Question #30
A “There is no real difference; dalteparin is interchangeable with regular heparin.”
B “The only difference is that regular heparin dosing is based on the patient’s weight.”
C “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
D “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
Question #31
A Utilize the Z-track method to inject the medication.
B Rub the administration site after injecting.
C Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
D Administer the medication into subcutaneous tissue of the abdomen.
Question #32
A “I will avoid contact sports.”
B “I will contact my health care provider if I develop excessive bruising.”
C “I will increase dark green leafy vegetables in my diet.”
D “I will take my medication at the same time each day.”
Question #33
A Protamine sulfate
B Vitamin K
C Vitamin E
D Calcium gluconate
Question #34
A Warfarin daily
B Vitamin K daily
C Aspirin daily (i.e., 81 mg)
D Recombinant factors
Question #35
A Transient ischemic attack
B Acute unstable angina
C Peripheral vascular disease
D Vitamin K deficiency
Question #36
A Heparin subcutaneously
B Warfarin orally
C Enoxaparin intramuscularly
D Dabigatran orally
Question #37
A Over-the-counter medications
B Urine culture
C Ingestion of acetaminophen
D Platelet level
Question #38
A October 1
B August 29
C July 31
D September 15
Question #39
A Edema
B Nausea
C Chest pain
D Itching
Question #40
A Blood urea nitrogen (BUN) level of 12 mg/dL
B Platelet count of 150,000 mm3
C Activated partial thromboplastin time (aPTT) of 120 seconds
D International normalized ratio (INR) of 1.0
Question #41
A Fasting blood glucose level of 95 mg/dL
B Platelet count of 75,000 cell/μL
C Creatinine clearance value of 40 mL/min
D Hemoglobin level of 16.5 g/dL
Question #42
A Thrombin
B Antithrombin III
C Vitamin K
D Factor Xa
Question #43
A Aminocaproic acid
B Tranexamic acid
C Alteplase
D Desmopressin
Question #44
A Anticoagulant
B Antiplatelet
C Thrombolytic
D Antifibrinolytic
Question #45
A Coronary artery disease
B Cardiomyopathy
C Heart failure
D Acute myocardial infarction
Question #46
A Dipyridamole
B Pentoxifylline
C Cilostazol
D Aspirin
Question #47
A Enoxaparin
B Argatroban
C Fondaparinux
D Dabigatran
Question #48
A Warfarin
B Direct thrombin inhibitors
C Selective factor Xa inhibitors
D Heparins
Question #49
A Anticoagulants dissolve clots.
B Anticoagulants interfere with drug metabolism.
C Anticoagulants alter platelet function.
D Anticoagulants prevent clots from forming.
Question #50
A Anticoagulant
B Antifibrinolytic
C Thrombolytic
D Antiplatelet
Question #51
A Anxiety
B Embolus to the lungs
C Fatigue from walking with pain
D Medication reaction
Question #52
A Administering protamine sulfate
B Infusing 50 mL of warfarin sodium
C Administering vitamin K1
D Increasing the dose of enoxaparin
Question #53
A Aspirin
B Calcium
C Vitamin K
D Potassium